Naloxone for Opioid Associated Out of Hospital Cardiac Arrest

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

November 30, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Heart Arrest, Out-Of-HospitalOpioid OverdoseNaloxone
Interventions
DRUG

Naloxone 2 MG

The intervention consists of naloxone 2mg (2ml of 1mg/ml solution) administered by EMS personnel via the IV or IO route. The study intervention will be administered immediately (within 5 minutes) following the first dose of epinephrine. When naloxone hydrochloride is administered intravenously, the onset of action is generally apparent within two minutes. The naloxone will be administered following the first dose of epinephrine. The control is saline 2ml will be supplied in pre-filled syringes within numbered trial treatment packs. They will be identical in appearance to the naloxone syringes.

DRUG

Saline 2ml

Placebo

Trial Locations (1)

94122

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER